Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoansLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colony Bankcorp (CBAN) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for Colony Bankcorp (CBAN) over the last 14 years, with Q1 2023 value amounting to $17.6 billion.

  • Colony Bankcorp's Shares Outstanding rose 4.29% to $17.6 billion in Q1 2023 from the same period last year, while for Mar 2023 it was $17.6 billion, marking a year-over-year increase of 4.29%. This contributed to the annual value of $17.6 billion for FY2022, which is 2869.87% up from last year.
  • Per Colony Bankcorp's latest filing, its Shares Outstanding stood at $17.6 billion for Q1 2023, which was up 4.29% from $17.6 billion recorded in Q4 2022.
  • Colony Bankcorp's 5-year Shares Outstanding high stood at $17.6 billion for Q4 2022, and its period low was $8.4 million during Q1 2019.
  • Moreover, its 5-year median value for Shares Outstanding was $9.5 million (2019), whereas its average is $3.9 billion.
  • Its Shares Outstanding has fluctuated over the past 5 years, first changed by 0.0% in 2020, then surged by 18503878.3% in 2022.
  • Colony Bankcorp's Shares Outstanding (Quarter) stood at $9.5 million in 2019, then changed by 0.0% to $9.5 million in 2020, then skyrocketed by 143854.21% to $13.7 billion in 2021, then grew by 28.7% to $17.6 billion in 2022, then fell by 0.02% to $17.6 billion in 2023.
  • Its Shares Outstanding was $17.6 billion in Q1 2023, compared to $17.6 billion in Q4 2022 and $17.6 million in Q3 2022.